SCHEMBL26564978

SCHEMBL26564978

COC(=O)CNC(=O)c1ccc(Oc2ccc(C#N)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP15 Q460N3 1/20 0.54
PARP10 Q53GL7 1/20 0.54
PARP2 Q9UGN5 1/20 0.54
KDM4E B2RXH2 3/20 0.52
GAA P10253 1/20 0.52
EGLN1 Q9GZT9 1/20 0.52
EPHX2 P34913 1/20 0.51
XDH P47989 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
RAB9A P51151 3/20 0.50
PPARA Q07869 1/20 0.50
POLB P06746 2/20 0.49
MAPT P10636 2/20 0.49
MAPK1 P28482 2/20 0.49
LMNA P02545 1/20 0.49
PKM P14618 1/20 0.49
IL18 Q14116 1/20 0.49
MMP1 P03956 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8718154 0.89 EGLN1 (0.64) KDM4EGAAEGLN1EPHX2XDH
SCHEMBL8947296 0.82 MMP1 (0.68) KDM4EGAAMEN1KMT2APOLB
SCHEMBL26561269 0.82 MMP13 (0.66) KDM4EGAAMEN1KMT2ARAB9A
SCHEMBL9269300 0.82 RAB9A (0.48) KDM4EEGLN1EPHX2MEN1KMT2A
SCHEMBL29035428 0.81 SMN1; SMN2 (0.64) KDM4EGAAMEN1KMT2ARAB9A
SCHEMBL5830902 0.81 PARP15 (0.55) PARP15PARP10PARP2KDM4EEPHX2
SCHEMBL25365642 0.80 MAPK14 (0.61) KDM4EGAAMEN1KMT2ARAB9A
SCHEMBL8947242 0.80 KMT2A (0.67) KDM4EGAAXDHMEN1KMT2A
SCHEMBL29523717 0.79 KDM4E (0.50) KDM4EGAAEPHX2MEN1KMT2A
SCHEMBL26564743 0.79 SMN1; SMN2 (0.59) KDM4EGAAMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed